Type 1 diabetes mellitus Trials in Boston, United States
Conditions / Type 1 diabetes mellitus / Boston, United States
Type 1 diabetes mellitus has been the subject of sustained clinical investigation across multiple research sites.
50 total trials for this combination
Showing top 10 of 50 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT04429503 | Study of a High-Dose Aflibercept in Participants With Diabetic Eye Disease | COMPLETED | PHASE2/PHASE3 |
| NCT03740919 | A Study Comparing LY900014 to Insulin Lispro (Humalog) in Children and Adolescents With Type 1 Diabetes | COMPLETED | PHASE3 |
| NCT03860558 | Impact of Metabolic Health on Sperm Epigenetic Marks in Humans | ACTIVE_NOT_RECRUITING | NA |
| NCT05018585 | A Phase III Study to Investigate if the Study Drug Diamyd Can Preserve Insulin Production and Improve Glycemic Control in Patients Newly Diagnosed With Type 1 Diabetes | ACTIVE_NOT_RECRUITING | — |
| NCT05901831 | A Study to Learn How Well the Study Treatment Finerenone Works and How Safe it is in People With Long-term Decrease in the Kidneys' Ability to Work Properly (Chronic Kidney Disease) Together With Type 1 Diabetes | COMPLETED | PHASE3 |
| NCT06111586 | FrexalimAB in Preservation of Endogenous insULIN Secretion Compared to Placebo in adUlts and Adolescents on Top of inSulin Therapy (FABULINUS) | RECRUITING | PHASE2 |
| NCT00385697 | The Protégé Study - Clinical Trial of MGA031 in Children and Adults With Recent-Onset Type 1 Diabetes Mellitus | COMPLETED | PHASE2/PHASE3 |
| NCT02384941 | Efficacy, Safety, and Tolerability Study of Sotagliflozin as Adjunct Therapy in Adult Patients With Type 1 Diabetes Mellitus Who Have Inadequate Glycemic Control With Insulin Therapy | COMPLETED | PHASE3 |
| NCT06783309 | CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D) | RECRUITING | PHASE1/PHASE2 |
| NCT00920582 | Protege Encore Study- Clinical Trial of Teplizumab (MGA031) in Children and Adults With Recent-Onset Type 1 Diabetes Mellitus | TERMINATED | PHASE3 |